Harpoon Therapeutics Inc
(HARP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,572 | -41,304 | -25,396 | -13,579 | -27,366 |
| Depreciation Amortization | 359 | -82 | 375 | 252 | 644 |
| Accounts payable and accrued liabilities | -1,761 | -697 | -876 | -771 | N/A |
| Other Working Capital | 49,049 | 2,239 | -1,949 | 245 | -1,076 |
| Other Operating Activity | 5,034 | 3,235 | 2,474 | 1,428 | 672 |
| Operating Cash Flow | $-2,891 | $-36,609 | $-25,372 | $-12,425 | $-27,126 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -65,799 | -63,897 | -81,459 | -51,577 | N/A |
| PPE Investments | -3,516 | -3,147 | -1,393 | -72 | -663 |
| Investing Cash Flow | $-69,315 | $-67,044 | $-82,852 | $-51,649 | $-663 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 803 | 277 | 161 | 34 | N/A |
| Other Financing Activity | 70,646 | 70,647 | 70,664 | 70,473 | 88,326 |
| Financing Cash Flow | $71,449 | $70,924 | $70,825 | $70,507 | $88,326 |
| Beginning Cash Position | 89,960 | 89,960 | 89,960 | 89,960 | 29,423 |
| End Cash Position | 89,203 | 57,231 | 52,561 | 96,393 | 89,960 |
| Net Cash Flow | $-757 | $-32,729 | $-37,399 | $6,433 | $60,537 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,891 | -36,609 | -25,372 | -12,425 | -27,126 |
| Capital Expenditure | -3,516 | -3,147 | -1,393 | -72 | N/A |
| Free Cash Flow | -6,407 | -39,756 | -26,765 | -12,497 | -27,126 |